Prazoles Targeting Tsg101 Inhibit Release of Epstein-Barr Virus following Reactivation from Latency

Abstract excerpt

Production of virions is necessary for the ubiquitous Epstein-Barr virus (EBV) to persist in humans and can set the stage for development of EBV cancers in at-risk individuals. In our attempts to identify inhibitors of the EBV lytic phase, we previously found that a prazole proton pump inhibitor, known to block the interaction of ubiquitin with the ESCRT-1 factor Tsg101, blocks production of EBV. We now find that...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Lymphoma Diagnosis and Treatment
• Share to Peptidase Inhibition and Analysis
• Share to Viral-associated cancers and disorders